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Ex vivo expansion of satellite cells and directed
differentiation of pluripotent cells to mature skeletal
muscle have proved difficult challenges for regener-
ative biology. Using a zebrafish embryo culture sys-
tem with reporters of early and late skeletal muscle
differentiation, we examined the influence of 2,400
chemicals on myogenesis and identified six that
expanded muscle progenitors, including three
GSK3b inhibitors, two calpain inhibitors, and one
adenylyl cyclase activator, forskolin. Forskolin also
enhanced proliferation of mouse satellite cells in cul-
ture and maintained their ability to engraft muscle
in vivo. A combination of bFGF, forskolin, and the
GSK3b inhibitor BIO induced skeletal muscle differ-
entiation in human induced pluripotent stem cells
(iPSCs) and produced engraftable myogenic progen-
itors that contributed tomuscle repair in vivo. In sum-
mary, these studies reveal functionally conserved
pathways regulating myogenesis across species
and identify chemical compounds that expand
mouse satellite cells and differentiate human iPSCs
into engraftable muscle.
INTRODUCTION
Skeletal muscle is a highly specialized tissue composed of
nondividing, multinucleated muscle fibers that contract to
generate force. Skeletal muscle is formed during embryogenesis
in a region of the embryo known as the myotome. In addition togenerating differentiated muscle fibers, embryonic progenitor
cells also give rise to specialized muscle-forming stem cells,
known as satellite cells (Gros et al., 2005; Seale et al., 2000).
Injury-induced satellite cell proliferation both replenishes the
satellite cell pool and produces differentiated myoblasts, which
fuse with existing myofibers and one another to regenerate mus-
cle tissue.
Satellite cells are defined anatomically by their localization
beneath the basal lamina of muscle fibers (Mauro, 1961) and
molecularly by their expression of the paired-box transcription
factor Pax7 (Seale et al., 2000). Transplantation-based studies
in animal models have demonstrated the utility of engrafted sat-
ellite cells for regenerating diseased muscle (Cerletti et al., 2008;
Fukada et al., 2004; Kuang et al., 2007; Montarras et al., 2005;
Sacco et al., 2008; Sherwood et al., 2004; Tanaka et al., 2009),
and analyses of mouse and human muscles indicate that their
loss during aging contributes to age-associated muscle weak-
ness (Brack et al., 2005; Cerletti et al., 2012; Chakkalakal et al.,
2012; Shefer et al., 2010). Thus, muscle satellite cells are prom-
ising targets for cell therapies, but the realization of this promise
has been hindered by the paucity of satellite cells that can be iso-
lated or expanded from adult muscle tissue.
In contrast to satellite cells, embryonic stem cells (ESCs) and,
more recently, induced pluripotent stem cells (iPSCs), can
expand indefinitely in culture. Although some success has
been achieved in directing the myogenic differentiation of
ESCs/IPSCs through genetic manipulation, selective culture,
and cell sorting approaches (Awaya et al., 2012; Barberi et al.,
2007; Darabi et al., 2008; Mizuno et al., 2010; Zheng et al.,
2006), the generation of well-differentiated muscle cells from hu-
man or murine pluripotent cells has proved challenging. In this
study, we took a cross-systems approach to identify conserved
molecular pathways that regulate muscle specification andCell 155, 909–921, November 7, 2013 ª2013 Elsevier Inc. 909
Figure 1. A Chemical Genetic Screen to Identify Modifiers of Skeletal Muscle Development
(A) myf5-GFP;mylz2-mCherry double-transgenic expression recapitulates expression of the endogenous genes. myf5-GFP is first detected at the 11-somite
stage. mylz2-mCherry expression is not observed until 32 hpf. Scale bars represent 200 mm.
(B) myf5-GFP;mylz2-mCherry embryos were dissociated at the oblong stage and cultured in zESC medium. Images were taken 48 hr after plating. Scale bars
represent 250 mm.
(C) Expression of myogenic genes measured by qRT-PCR. Blastomere cells were cultured and harvested at 24 hr. Error bars represent SD from the triplicate
reactions. All values are normalized to b-actin and expression data of basic medium (gray bars, lacking bFGF) are set to 1.
(D) Expression of myogenic genes by different populations of blastomere cells isolated by FACS after 24 hr culture with bFGF. Error bars represent SD from
triplicate reactions. Expression data are normalized to b-actin, and expression values of double-negative population (blue bars) are set to 1.
See also Figure S1.satellite cell expansion in three vertebrate systems. Capitalizing
on chemical genetics approaches in zebrafish, we performed a
high-throughput image-based screen using zebrafish blasto-
mere cells and identified 28 chemicals that perturb muscle
development and 6 that promote myogenesis. We tested the
muscle-promoting compounds against mouse satellite cells
and human iPSCs to identify conserved activities. Forskolin, an
adenylyl cyclase activator, significantly increased satellite cell
proliferation in culture, expanding the capacity of these cells to
regenerate dystrophic muscle upon transplantation. In addition,
combination of bFGF, the GSK3b inhibitor BIO, and forskolin
drove skeletal muscle specification of human iPSCs, including
spontaneous differentiation to mature myofibers and the pro-
duction of myogenic progenitors that contributed to muscle
fibers and satellite cells when transplanted into immune-
compromised mice. Our studies thus elucidate a combination
of chemicals that promotes muscle development in fish, mouse,
and human cells and establish a system to generate and expand
mammalian muscle stem cells for functional studies of muscle
development and therapeutics for musculoskeletal diseases.
RESULTS
A Zebrafish Embryo Culture System to Examine Skeletal
Muscle Development
Myogenic commitment is signified by expression of myoD and
myf5 (Weinberg et al., 1996), which are functionally redundant910 Cell 155, 909–921, November 7, 2013 ª2013 Elsevier Inc.and exhibit overlapping expression in the earliest myogenic
precursors (Hinits et al., 2009). Terminal differentiation of these
progenitors produces cells expressing genes encoding mus-
cle-specific structural proteins like myosin light polypeptide 2
(mylz2) (Ju et al., 2003). To label different developmental states
of muscle cells in zebrafish embryos, we generated a myf5-
GFP;mylz2-mCherry double transgenic zebrafish line. At the
11-somite stage, myf5-GFP expression was restricted to the
newly formed somite, and no mylz2-mCherry expression was
detected (Figure 1A). Expression ofmylz2-mCherry was first de-
tected at 30 hr postfertilization (hpf) in the anterior somites and
later spread to the posterior somites (Figure 1A). These data indi-
cate that expression of myf5-GFP and mylz2-mCherry recapitu-
lates the expression patterns of their corresponding endogenous
genes (Thisse et al., 2001) and thus can be used to track
myogenic specification from early embryonic progenitors.
To test whether zebrafish blastomere cells could form muscle
in vitro, we disassociated myf5-GFP;mylz2-mCherry embryos
at the oblong stage and plated them on gelatin-coated dishes.
1%–10% of cells cultured in zebrafish ESC (zESC) medium
(Fan and Collodi, 2006) becameGFP positive, indicating upregu-
lation of myf5 expression. Among the GFP-positive cells,
1%–5% were also mCherry (mylz2) positive, suggesting that
myogenic specification and differentiation had occurred
(Figure 1B).
Loss of FGF signaling in fgf24 and fgf8 double-deficient zebra-
fish essentially blocks embryonic muscle development (Draper
Figure 2. Chemical Genetic Screens to
Identify Modifiers of Skeletal Muscle Devel-
opment
(A) Schematic of a high-throughput image-based
chemical screening assay. Approximately 800
myf5-GFP;mylz2-mCherry double-transgenic
embryos were collected and dissociated at the
oblong stage. Resulting blastomere cells were
aliquotted into four 384-well plates with preadded
chemicals. After 2 days, the 384-well plates were
imaged and analyzed using a Celigo cytometer.
(B) Sample images from the modifier screen. Hits
could be grouped into three categories. Category I
has only myf5-GFP expression. Category II has a
decreased amount of both fluorescent colors.
Category III has increased expression of both.
Scale bars represent 250 mm.
(C) Hits from the enhancer screen. Six chemicals
that increase the GFP and mCherry signals were
identified. Scale bars represent 250 mM.
See also Figure S2 and Tables S1 and S2.et al., 2003), and FGF signals directly activate myoD expression
in Xenopus (Fisher et al., 2002). Based on these data, we added
bFGF to the embryo cultures. The majority of bFGF-treated cells
became GFP and mCherry double positive, indicating a potent
muscle-promoting effect (Figures 1B and S1A available online).
Other myogenic genes, including myoD, mrf4, pax7, and myog,
were also induced by blastomere cells cultured with bFGF
(Figure 1C). Compared to the GFP/mCherry double-negative
population, both the myf5-GFP+;mylz2-mCherry and the
double-positive population isolated by FACS showed enriched
myogenic gene expression and lower expression of blood
(embryonic globin) and liver (ifabp) genes. Double-positive cells
expressed higher levels of myoD and mylz2 than myf5-GFP+;
mylz2-mCherry cells, suggesting that, similar to the in vivo sit-
uation (Figure 1A), myf5-GFP and mylz2-mCherry label stage-
specific myogenic populations in these in vitro cultures
(Figure 1D).
To validate this in vitro myogenesis system, we determined
whether genes required for muscle development in vivo were
also required in culture. Zebrafish embryos injected with myf5
and myoD double morpholinos are immobile, presumably due
to defectivemuscle development (Schnapp et al., 2009). Expres-
sion of myogenic regulatory factors (mrfs), like myogenin and
mrf4, and genes encoding structural proteins, like myosin heavy
chain (mhc) and mylz2, are absent in the double morphant
(Schnapp et al., 2009). Consistent with these data, embryos
injected with double morpholinos lacked myf5-GFP and mylz2-
mCherry expression at 30 hpf (Figure S1B). Cultured blastomere
cells from the double morphant also showed dramatically
decreased expression of myf5-GFP and mylz2-mCherry
(Figure S1C).
A Chemical Genetic Screen Identifies Modifiers of
Skeletal Muscle Development
To enable higher throughput analysis of myogenesis modifiers,
the embryo culture system was adapted to a semiautomatedscreening platform. myf5-GFP;mylz2-mCherry embryos were
disassociated at the oblong stage, and the resulting individual
blastomere cells were aliquoted into four 384-well plates with
preadded chemicals. Culture medium was supplemented with
bFGF to promote muscle development. After 1 day, the cells
were automatically imaged (Figure 2A).
We screened 2,400 chemicals from a bioactive drug library
(Table S3) and identified 28 that perturbed the GFP or mCherry
signals with undetectable toxicity. Based on changes in GFP
(Myf5) and mCherry (Mylz2) signals, these 28 hits could be
divided into three categories. Category I compounds produced
cultures with only myf5-GFP-positive cells, a phenotype likely
caused by blocking differentiation of muscle progenitors into
mature muscle cells (Figure 2B and Table S1). Ten chemicals,
including inhibitors of the p38 pathway, previously shown to be
required for muscle formation (Cuenda and Cohen, 1999; Wu
et al., 2000; Zetser et al., 1999), were included in category I.
Category II included 17 chemicals that reduced the number of
cells expressing either fluorescent color, likely because these
chemicals block commitment of mesoderm progenitors to the
muscle progenitor fate (Figure 2B and Table S2). Category III
held only one compound (SB415286, a GSK3b inhibitor), which
increased expression of both markers, presumably by acceler-
ating muscle development (Figure 2B).
To test whether these chemicalsmodulatemyogenesis in vivo,
we treated zebrafish embryos with each of the category II chem-
icals and evaluated the effect on myoD expression at the 6-
somite stage. Among the 17 compounds tested, 11 caused
decreased myoD expression in vivo, 2 induced nonspecific
toxicity, and 4 produced no apparent effect (Figure S2A and Ta-
ble S2). 65% of the hits identified in our initial in vitro screen also
perturbed muscle development in vivo, suggesting that this
screening system can reveal in vivo muscle biology.
bFGF induces muscle development by activating the FGF re-
ceptor tyrosine kinase (RTK). We identified three RTK inhibitors
that block the muscle-promoting effect of bFGF (Figure S2B).Cell 155, 909–921, November 7, 2013 ª2013 Elsevier Inc. 911
bFGF activates several intracellular pathways, including those
involving MEK/ERK and phosphoinositide-3-kinase (PI3K)-AKT
(Figure S2C). No MEK/ERK inhibitor was found to inhibit muscle
development (Figure S2B). In contrast, the PI3K inhibitor LY-
294002 completely blocked the muscle-promoting effect of
bFGF (Figure S2B). Another PI3K inhibitor, wortmannin, had a
similar effect (Figure S2B). Treatment with rapamycin, an
mTOR inhibitor, blocked myogenesis induced by bFGF (Fig-
ure S2B). These results suggest that bFGF promotes myogene-
sis through the PI3K-mTOR—rather than MEK/ERK—signaling
pathway, although full mechanistic understanding of bFGF’s
promyogenic effect in this systemawaitsmore detailed analyses.
A Sensitized Chemical Genetic Screen Identifies
Enhancers of Skeletal Muscle Development
The strong muscle-promoting effect of bFGF made it difficult to
identify enhancers of myogenesis in our original system. To
sensitize the system for enhancers of muscle development, we
repeated the screen in the absence of bFGF. In this sensitized
screen, 6 chemicals out of 2,400 were identified to increase
the GFP and mCherry signals (Figures 2C and S2D). These hits
included three GSK3b inhibitors, two calpain inhibitors, and
one cAMP activator forskolin.
None of the six chemicals increased myoD expression when
applied to wild-type embryos, presumably due to a masking
effect of the endogenous muscle program (data not shown). To
evaluate the interaction of these chemicals with the FGF
pathway, we injected embryos with morpholinos targeting fgf8
and fgf24 and assessed the ability of each chemical to rescue
muscle development of fgf8;fgf24 double morphants, which dis-
played defective myogenesis as previously reported (Draper
et al., 2003). Of the six compounds tested, only forskolin rescued
the myogenesis defect, indicating a unique activity of forskolin
compared to the other compounds (Figure S2E).
Forskolin Treatment Elevates cAMPLevels and Expands
Mouse Satellite Cells In Vitro
We hypothesized that chemical hits enhancing skeletal muscle
development in zebrafish blastomeres might likewise promote
muscle precursor cell formation and/or expansion in other spe-
cies. We exposed satellite cells isolated by fluorescence-acti-
vated cell sorting (FACS) (Cerletti et al., 2008; Sherwood et al.,
2004) from adult mouse skeletal muscle to these compounds.
Satellite cells were cultured in the presence of different concen-
trations of each myogenesis-promoting chemical. Of the six
chemicals tested, only forskolin triggered dose-dependent
expansion of satellite cell cultures (data not shown). The number
of cells in these cultures was increased by forskolin both in the
presence and absence of bFGF (Figure 3A). Forskolin treatment
also increased cell number in satellite cell cultures seeded from
mdx mice, a model of Duchenne muscular dystrophy (DMD)
(Sicinski et al., 1989) (Figures 3B and S3A). The expanded for-
skolin-treated cells maintained expression of Pax7 and showed
upregulation of MyoD, a marker profile consistent with activated
satellite cells (Figure S3B).
To evaluate the mechanism by which forskolin drives
increased cell number in satellite cell cultures, we assayed cyclic
AMP (cAMP) production (Metzger and Lindner, 1981; Seamon912 Cell 155, 909–921, November 7, 2013 ª2013 Elsevier Inc.et al., 1981) and found that forskolin treatment increased
cAMP levels in mouse satellite cell cultures (Figure 3C). We
also performed cell survival and proliferation assays in forsko-
lin-treated cultures. Satellite cells were plated at one cell per
well in 96-well plates and treated with forskolin or DMSO. After
6 days, we quantified the number of wells containing any number
of myogenic cells (a measure of cell survival; Cerletti et al., 2012)
and the number of cells in those wells (a measure of cell prolifer-
ation) (Figure 3D). The frequency of myogenic colony formation
did not differ between forskolin- and DMSO-treated cells (Fig-
ure 3E), suggesting that forskolin treatment does not affect cell
survival. Consistent with our earlier observations (Figure 3A),
myogenic colonies formed in the presence of forskolin contained
more cells than DMSO-treated colonies (Figure 3F). Forskolin-
treated satellite cells were not immortalized, however, andmain-
tained proliferative capacity in culture for approximately the
same length of time as DMSO-treated cells (data not shown).
To test whether the increase in cell proliferation was caused by
an inhibitory effect of forskolin on satellite cell differentiation, we
expanded cultured satellite cells and induced them to differen-
tiate in the presence or absence of forskolin. The percentage
of nuclei in myotubes in each culture was quantified as a mea-
sure of myogenic differentiation (Figure 4A) and was not different
between the forskolin and DMSO-treated groups (Figures 4B
and 4C). Satellite cells that were exposed to forskolin during
growth and then induced to differentiate after removal of the
compound (Figure 4D) also formed myotubes with the same
efficiency as control-treated cells (Figures 4E and 4F). Treatment
with forskolin during both the proliferative and differentiation
phases of culture also did not affect differentiation (Figures
S4D–S4F). Thus, forskolin-treated satellite cells exhibit unper-
turbed differentiation in vitro regardless of the timing of
compound exposure. Unlike the synergistic effect of bFGF and
forskolin for satellite cell expansion (Figure 3A), however, addi-
tion of bFGF during differentiation slightly reduced the number
of nuclei incorporated into myotubes (Figures S4A–S4C), sug-
gesting an inhibitory effect of bFGF on myogenic differentiation
in the presence of forskolin (Figures S4A–S4C).
Forskolin-Treated Cells Retain Phenotypic
Characteristics of Satellite Cells and Engraft into
Dystrophic Skeletal Muscle In Vivo
Muscle satellite cells are highly enriched within the subset of
myofiber-associated cells that coexpresses Cxcr4 and b1-
Integrin (Sherwood et al., 2004), and myogenic cells lacking
CXCR4 and b1 integrin fail to engraft into mdx muscle (Cerletti
et al., 2008). High levels of Cxcr4 expression also predict high
levels of Pax7 expression, which identifies a subset of serially
transplantable satellite cells with muscle-stem-cell-like proper-
ties (Rocheteau et al., 2012). Freshly isolated satellite cells are
100% positive for CXCR4 and b-1 integrin expression, and
flow cytometric analysis revealed that 78.9% ± 1.52% of forsko-
lin-expanded cells maintained coexpression of both these
markers after 5 days in culture (Figures 5A and 5B). Thus, most
satellite cells cultured in forskolin retain phenotypic characteris-
tics of freshly isolated, engraftable muscle stem cells.
To assess directly the engraftment potential of cultured for-
skolin-treated satellite cells, we isolated cells from b-actin-GFP
A B
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Figure 3. Forskolin Treatment Elevates
cAMP Level and Increases Proliferation of
Satellite Cells from Both Healthy and
Dystrophic Mice
(A) Satellite cells from C57BL/6J mice were
cultured and treated with DMSO or forskolin in the
absence or presence of bFGF, as indicated. Total
cell number was determined after 5 days (mean ±
SEM, n = 4). Data are presented as fold change,
normalized to ‘‘DMSO no bFGF’’ controls.
(B) Fold change in cell number from cultures of
mdx satellite cells after 5 days in vitro with bFGF
alone, DMSO + bFGF, or forskolin + bFGF (mean ±
SEM, n = 4). Data are normalized to
‘‘DMSO +bFGF’’ controls.
(C) Concentration of cAMP in cultured satellite
cells is increased after treatment with 25 mM,
50 mM, or 100 mM of forskolin, as compared to the
DMSO-treated cells (mean ± SD, n = 5). Data are
normalized ‘‘DMSO’’ controls.
(D) Experimental scheme for myogenic colony-
forming assay. Satellite cells were isolated from
C57BL/6J mice, and a single cell was plated into
each well of 96-well plates. Cells were cultured for
6 days and treated with DMSO or forskolin. The
number of wells containing amyogenic colony and
the number of cells in each colony were counted
after 6 days.
(E) Clonal plating efficiency of satellite cells is not
altered by forskolin treatment, as compared to
DMSO-treated cells (mean ± SD, n = 4).
(F) Forskolin treatment increases the number of
myogenic cells arising from a single satellite cell in
each well, showing an increase in cell proliferation.
Data are plotted as the % of colonies containing
the indicated number of cells (mean ± SD, n = 4).
H, p < 0.05; HH, p < 0.01.
See also Figure S3.transgenic mice (Wright et al., 2001) using GFP as a marker for
cell tracking in transplantation experiments. 6,000GFP-express-
ing satellite cells were cultured for 5 days with forskolin, and the
resulting cells were transplanted into the preinjured muscles of
mdx mice (Figure 5C). Recipient muscles were harvested
3–4 weeks after transplant and analyzed for the presence of
donor-engrafted, GFP-expressing myofibers. Consistent with
the ability of forskolin to expand a primitive and engraftable
myogenic cell population, the number of GFP+ fibers was higher
in animals receiving forskolin-expanded cells as compared to
those receiving the original number of freshly isolated satellite
cells or those receiving expanded DMSO-treated cells (Figures
5E and 5G). In contrast, the number of engrafted fibers did not
differ significantly when recipients were transplanted with equal
numbers of cultured DMSO or forskolin-treated cells (Figures 5F
and 5H). Thus, exposure to forskolin expands mouse satellite
cells in culture while maintaining their engraftment potential.
This effect provides more cells for transplantation (Figure 5D)
and a greater yield of engrafted fibers in vivo if the same number
of satellite cells is first expandedwith forskolin in vitro, compared
to control. Myofibers engrafted by forskolin-treated cells stained
for Dystrophin, which normally is absent in mdx muscle
(Figure S3C), indicating that forskolin-expanded donor cells
maintain in vivo myogenic activity and can produce functionalmyoblasts that incorporate into myofibers and produce mus-
cle-specific proteins.
ACombination of bFGF, BIO, and Forskolin Activates the
Skeletal Muscle Program in iPSCs
It is currently difficult to differentiate human iPSCs or ESCs to the
skeletal muscle lineage, with the greatest successes involving
ectopic introduction and overexpression of muscle-specific
transcription factor genes (Darabi et al., 2012; Tedesco et al.,
2012). Strategies to drive myogenic differentiation of pluripotent
cells in the absence of ectopic transcription factor expression
have typically required multistep culture and cell-sorting proto-
cols that are very time and labor intensive (Awaya et al., 2012;
Barberi et al., 2007).
We tested the effects of muscle-promoting compounds
on the differentiation of three different lines of iPSCs (00409,
05400, and BJ) derived from healthy human donor skin fibro-
blasts by retroviral transduction with the reprogramming
factors Oct4, Klf4, Sox2, and c-Myc (Figures S5A–S5D).
Embryoid bodies (EB) from BJ, 00409, or 05400 iPSCs were
exposed for 7 days to a serum-free differentiation medium
containing bFGF (10 ng/ml), BIO (0.5 mM), and forskolin
(20 mM) (medium added at days 1, 3, and 5). We used BIO
rather than the GSK3b inhibitors found in the screen because,Cell 155, 909–921, November 7, 2013 ª2013 Elsevier Inc. 913
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Figure 4. Forskolin-Treated Satellite Cells Exhibit Effective Differentiation In Vitro
(A) Experimental scheme. Satellite cells fromC57BL/6Jmice were cultured in the presence of bFGF for 5 days. Cells were harvested on day 5, and equal numbers
of cells were induced to differentiate in the presence of forskolin or DMSO.
(B) Images of satellite cells differentiated in the presence of DMSO (left) or forskolin (right) and stained for myosin heavy chain (MHC, red) and nuclei (blue). Scale
bars represent 200 mm.
(C) Quantification of percentage of nuclei in myotubes after satellite cell differentiation in the presence of forskolin or DMSO (mean ± SEM, n = 4). Differentiation
potential of satellite cells is unaffected by forskolin (p = nonsignificant [NS]).
(D) Satellite cells from C57BL/6J mice were cultured with bFGF and forskolin/DMSO for 5 days. Cells were harvested on day 5, and equal numbers of cells were
induced to differentiate after removal of the compound.
(E) Images of DMSO- (left) or forskolin (right)-treated satellite cells differentiated after removal of compound and were stained for MHC (red) and nuclei (blue).
Scale bars represent 200 mm.
(F) Quantification of percentage of nuclei in myotubes after differentiation of forskolin- or DMSO-treated cells (mean ± SEM, n = 5). Forskolin-treated satellite cells
show no defect in myotube formation.
See also Figure S4.of the several GSK3b antagonists tested, BIO displayed
the lowest toxicity on monolayer iPSCs and differentiating
EBs (Figures S5E and S5F). After 7 days, we measured the
expression of a panel of markers specific for ectoderm,
endoderm, or mesoderm to assess differentiation outcomes.
The mesodermal markers GATA2, PAX7, MYF5, and MYOD1
genes were significantly upregulated after 2, 4, and 7 days
of differentiation, compared to the corresponding undifferenti-
ated iPSCs (Figures 6A, S6A, and S6B). In contrast, ectodermal
and endodermal genes were not significantly altered. Immuno-914 Cell 155, 909–921, November 7, 2013 ª2013 Elsevier Inc.staining experiments confirmed these results and showed
that muscle-specific proteins (PAX7, MYF5, and MYOD1)
were present in the nuclei of EB cells differentiating under
these conditions (Figure S6F). These data suggest that this
three-chemical mixture specifically favors the mesodermal
lineage and promotes myogenic specification. Two-way
combinations, such as bFGF + BIO or bFGF + forskolin, yielded
significantly less potent myogenic induction as compared to
the bFGF/BIO/forskolin ‘‘triple cocktail’’ (Figures S5G and
S5H).
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Figure 5. Forskolin-Treated Cultured Satellite Cells Retain Immunophenotypic Characteristics of Freshly Isolated Satellite Cells and Engraft
Skeletal Muscle In Vivo
(A) Representative FACS plots depict CD45SCA-1MAC1 cells gated for the CXCR4+ and b1 Integrin+ subset of freshly isolated (left) and cultured satellite cells
(initially sorted as 100% CXCR4+ and b-1 Integrin+) treated with DMSO (middle) or forskolin (right).
(B) Average frequency (mean ± SEM, n = 6) of CXCR4+b1-Integrin+ cells among cultured satellite cells treated with DMSO or forskolin, quantified by FACS. Most
cultured satellite cells were treated with either DMSO or forskolin retain expression of CXCR4 and b1 Integrin.
(C) Experimental scheme. GFP+ satellite cells were harvested from b-actin-GFP mice and were transplanted into the TA muscle of recipient mdx mice, injured
1 day previously by injection of cardiotoxin. Cells were transplanted either immediately after isolation or following 5 days in culture with DMSO or forskolin
treatment.
(D) Total number of cultured GFP+ satellite cells that were obtained from 6,000 freshly isolated cells and used for transplantation intomdxmuscle. Cell number
was, on average, 2.5 times greater in forskolin-treated as compared to DMSO-treated cultures (mean ± SD, n = 6).
(E) Transverse frozen section of TA muscle from mdx mice transplanted with 6,000 freshly isolated satellite cells (left), cultured DMSO-treated satellite cells
expanded from 6,000 freshly isolated cells (middle), or cultured forskolin-treated satellite cells expanded from 6,000 freshly isolated cells (right). Laminin staining
is shown in red. Scale bars represent 200 mm.
(F) Transverse frozen sections of TA muscle from mdx mice transplanted with 200,000 cultured DMSO-treated (left) or 200,000 cultured forskolin-treated (right)
GFP+ satellite cells. Laminin staining is shown in red. Scale bars represent 200 mm.
(G) Quantification of donor-derived (GFP+) myofibers in mdx muscles transplanted with freshly isolated, DMSO-cultured, or forskolin-cultured satellite cells
(mean ± SD, n = 6).
(H) Quantification of donor-derived myofibers in mdx muscle transplanted with 200,000 cultured DMSO-treated or 200,000 cultured forskolin-treated satellite
cells (mean ± SD, n = 4).To determine whether iPSC-derived cells undergo terminal
skeletal muscle differentiation with bFGF/BIO/forskolin, EBs
were plated on matrigel-coated dishes for further differentiation.
Gene expression analysis of these cultures revealed that PAX7,MYOD1, andMYF5 remained increased after 36 days of culture.
Expression of Myogenin and MyHC, two markers of late
myogenic differentiation, increased after 20 days, and this in-
crease became more pronounced after 36 days (Figure 6B). AtCell 155, 909–921, November 7, 2013 ª2013 Elsevier Inc. 915
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Figure 6. Treatment of Human iPSCs with Muscle-Promoting Cocktail Induces Skeletal Muscle Differentiation
(A and B) Gene expression analysis of EBs (A) and monolayer cells (B). Cells were harvested at the times indicated for RNA extraction. Ectodermal, endodermal,
and mesodermal genes were analyzed by quantitative RT-PCR using GAPDH as a housekeeping gene. Changes in gene expression are indicated relative to
undifferentiated iPSCs (day 0). Bars represent the SD of three independent experiments (*p < 0.05, **p < 0.01, and ***p < 0.001).
(C) Immunostaining of differentiated iPSCs. Under terminal differentiating procedures (day 36), most of the cells express Desmin (red) and Myogenin (green),
forming multinucleated myofibers. Cells were also stained with Hoechst (blue). The number on each panel represents the percentage of cells expressing Desmin
and Myogenin. Scale bars represent 100 mm.
(D) Representative electron microscopy image of differentiated BJ iPSCs at day 36, magnification 352,700.
(E) Immunoelectron microscopy staining using skeletal-muscle-specific antimyosin heavy and light chain. Black dots indicate gold cross-linked particles to
secondary antibody, magnification 352,700.
See also Figures S5 and S6.day 36, we observed many multinucleated myotubes, which
stained for Desmin and Myogenin (Figure 6C). Although iPSCs
can differentiate spontaneously to cardiac cells, gene expres-
sion analysis revealed no increase in cardiac markers (NKX2.5
and GATA2) after 36 days of differentiation, and no spontane-
ously beating cells were found in the treated cultures. In contrast,916 Cell 155, 909–921, November 7, 2013 ª2013 Elsevier Inc.beating cells were observed in the untreated cell lines after 12–
14 days (data not shown). Thus, the three compounds together
induced a skeletal myogenic—rather than cardiogenic—
program.
We also confirmed the skeletal muscle fate of iPSC-derived
cells cultured in bFGF/BIO/forskolin by electron microscopy
Figure 7. Engraftment of Human iPSC-
Derived Muscle Progenitors into Immune-
Compromised Mice
Representative hematoxylin and eosin staining
(H&E) images and immunostaining on TA sections
of preinjured NSG mice injected with 1 3 105
iPSCs at day 14 of differentiation. Muscles in-
jectedwith BJ, 00409, or 05400 iPSC-derived cells
stain positively for human d-Sarcoglycan protein
(red). Fibers were counterstained with Laminin
(green). No staining is observed in PBS-injected
mice or when 00409 fibroblast cells were trans-
planted. Because the area of human cell engraft-
ment could not be specifically distinguished on
H&E stained sections, which must be processed
differently from sections for immunostaining, the
H&E images shown do not represent the same
muscle region as that shown in immunofluores-
cence images. Scale bars represent 100 mm, n = 3
per sample.
See also Figure S7.(EM) and immunogold staining with antihuman skeletal muscle
Myosin and heavy and light chain antibodies (sk-Myosin-HL-
Chains). EM analysis of BJ iPSC-derived cells harvested from
culture after 36 days revealed the presence of distinct sarcomere
structures, which stained positively for sk-Myosin-HL-Chains
(Figures 6D and 6E). Similar results were obtained in 00409
and 05400 iPSCs (Figures S6C–S6E).
iPSCs-Derived Muscle Progenitors Can Engraft into
Skeletal Muscle In Vivo
To determine whether myogenic specification using bFGF/BIO/
forskolin could generate or expand engraftable muscle progeni-
tors from human pluripotent cells, we assessed the ability of cells
derived from human iPSCs to support muscle regeneration
in vivo. BJ, 05400, or 00409 iPSCs were differentiated by treat-
ment with bFGF/BIO/forskolin and transplanted into immunode-
ficient mice after 14 days of differentiation. This time point was
chosen because expression of the satellite-cell-specific tran-
scription factor PAX7 peaks at 14 days (Figure 6B). iPSC-derived
cells were transplanted directly into the limb muscle of NOD/
SCID/IL2Rg/ (NSG) mice that had been preinjured by cardio-
toxin injection 24 hr before transplantation. The contralateral
muscles of recipient mice were injured but injected with only
PBS. One month after transplantation, muscles were harvestedCell 155, 909–921,and analyzed for engraftment by immu-
nostaining with human muscle-specific
d-Sarcoglycan antibody. PBS-injected
muscle showed no detectable staining
for human d-Sarcoglycan (Figure 7).
Human d-Sarcoglycan+ fibers were also
absent when 00409-derived fibroblast
cells were transplanted (Figure 7). By
contrast, transplantation of myogenic
progenitors derived from any of the three
iPSC lines (BJ, 05400, or 00409) yielded
significant engraftment of cells that
showed clear reactivity for human d-Sar-coglycan (Figure 7). To test whether engrafted cells also contrib-
uted to the satellite cell compartment in recipient muscles, we
performed immunostaining using human-specific histone H2A
and Pax7 antibodies. Pax7 and human H2A staining colocalized
in a subset of nuclei in the engrafted muscle, indicating that the
transplanted iPSC-derived cells also populated the satellite cell
compartment (Figures S7A and S7B). No human H2A staining
was observed in PBS-injected mice. Thus, iPSC-derived pro-
genitor cells generated by treatment with bFGF/BIO/forskolin
maintain myogenic commitment and support regenerative myo-
genesis after in vivo transplantation.
DISCUSSION
In this study, we took advantage of chemical genetic approaches
available in zebrafish to reveal conserved mechanisms control-
ling the specification and expansion of myogenic progenitor
cells. Although prior studies have employed chemical genetics
in whole zebrafish embryos to interrogate development and dis-
ease, this approach requires time-consuming manipulation of
embryos and whole-mount in situ hybridization. Some labora-
tories have screened embryos using high-speed pipetting and
imaging, but the three-dimensional structure of the embryo
makes this approach rather difficult. The culture-basedNovember 7, 2013 ª2013 Elsevier Inc. 917
screening system reported here takes one-sixth the time and
uses one-tenth the embryos. Such throughput enables
screening of larger chemical libraries with greater speed than
chemical screening on mammalian cell lines. Transgenic zebra-
fish with fluorescent reporters known to label a particular cell
type in vivo can be used, and images can be automatically
captured and stored such that the cells need not be fixed or
scored immediately. Recently, a zebrafish explant system with
some similarities to our embryo culture system identified com-
pounds that could expand angiogenic progenitors (Huang
et al., 2012). Our system is distinct in that it enables the combi-
nation of reporters of different colors to simultaneously interro-
gate multiple developmental states or lineages. Nevertheless,
both systems utilize zebrafish embryonic cells to examine
signaling events that participate in organ development in vitro.
A noteworthy attribute of the zebrafish embryo culture system
is its ability to identify pathways that influence tissue specifica-
tion and progenitor cell expansion across species. Chemicals
found in our zebrafish system expand postnatal muscle satellite
cells frommice and specify myogenic differentiation from human
pluripotent cells, thus helping to address two of the more vexing
challenges in the production of mammalian muscle precursors
for experimental applications and, ultimately, cell therapy. One
major obstacle in using purified skeletal muscle satellite cells
for therapy is their very low frequency in adult tissue. High
numbers of engraftable cells are required for functional recovery
of skeletal muscles throughout the body in genetic muscle disor-
ders, and efforts to expand purified satellite cells in culture while
maintaining their engraftment potential have been largely unsuc-
cessful (Montarras et al., 2005). We show that mouse muscle
progenitors treated with the adenylyl cyclase activator forskolin
exhibit enhanced proliferation in culture. These data are consis-
tent with a previous report showing that activation of cAMP
signaling in transgenic mice expressing an activated form of
cAMP response element binding protein (CREB) increases the
in vitro proliferation of primary myoblasts (Stewart et al., 2011)
and contrast with the cell-cycle inhibitory effects of this chemical
in some other systems (e.g., human T cells [Rodriguez et al.,
2013] and thyroid cancer cell lines [Yano et al., 2007]). Forskolin
does not inhibit satellite cell differentiation in vitro, and forskolin-
treated muscle progenitors differentiate normally after removal
of the compound or in its continued presence. Satellite cells
cultured with forskolin retain most phenotypic characteristics
of freshly isolated satellite cells. Forskolin may mimic activation
of a natural G-protein-coupled receptor involved in the genesis
or maintenance of muscle progenitors. When transplanted into
preinjured mdx muscle, forskolin-expanded satellite cells en-
grafted to generate Dystrophin-expressing myofibers. Forskolin
treatment also enhanced proliferation of satellite cells from
dystrophic mdx mice, which exhibited defective ex vivo expan-
sion under control conditions. Forskolin thus may be useful to
promote ex vivo expansion of human dystrophic satellite cells
for autologous therapy or to improve the efficiency of cell
replacement strategies for muscle disorders.
The capacity of forskolin to expand functional satellite cells
may explain the enhanced myogenesis observed in zebrafish
blastomeres and human iPSCs upon forskolin exposure. During
culture, some pluripotent cells likely differentiate to form muscle918 Cell 155, 909–921, November 7, 2013 ª2013 Elsevier Inc.progenitors, and forskolin may act to increase the proliferation of
these myogenic cells by activating cAMP signaling, thereby
enriching muscle-forming capacity. Given prior difficulties in
obtaining robust skeletal muscle differentiation from pluripotent
cells, most studies have relied on transgenic modification (Dar-
abi et al., 2012; Tedesco et al., 2012). By applying insights
obtained from our zebrafish embryo culture screen, we identified
a chemical cocktail that successfully enabled myogenic differ-
entiation of iPSCs into mature myofibers in vitro and in vivo in
the absence of genomic modification or transcription factor
overexpression. A screen to find such chemical inducers of mus-
cle development using iPSCs would have been highly reagent
and labor intensive, particularly as myogenic differentiation in
the human system requires 36 days. In contrast, the zebrafish
protocol takes only 1–2 days, enabling the completion of a small-
scale screen in about 1 week.
One remarkable aspect of the myogenic protocol defined here
is the selectivity with which the skeletal muscle fate is specified
during culture. Simultaneous inhibition of GSK3b and activation
of cAMP and bFGF pathways during EB formation are sufficient
to specifically promote commitment to skeletal muscle differen-
tiation, and our marker analysis indicates that alternative fates,
including cardiac and neural lineages, are relatively rare in cul-
tures exposed to the triple cocktail. Although we observed
modest variability in gene expression changes among the three
different iPSC lines used, likely reflecting differences in the ge-
netic background of the three different human donors, all three
lines exhibited potent muscle differentiation in response to the
bFGH/BIO/forskolin cocktail. Prior studies indicate that cAMP
signaling is increased at discrete times during embryonic muscle
differentiation and promotes regeneration and metabolic adap-
tation in satellite cells (Carlsen, 1975; Chen et al., 2005; Le Peuch
et al., 1979; Zalin and Montague, 1975). Myogenesis of muscle
stem cells can also be induced by Wnt activation (Brack et al.,
2008; Polesskaya et al., 2003), and bFGF-mediated activation
of PI3K-AKT pathway has been reported as a potent mediator
of muscle differentiation (Stitt et al., 2004). These results,
together with the ability to achieve myogenic specification of
iPSCs using a simple cocktail of defined chemicals, raise the
possibility that iPSC-derived myogenic cells could one day be
applied to regenerative cell therapy for the treatment of muscu-
loskeletal diseases. The findings reported here should prove
highly beneficial to understanding normal myogenesis and for
in vitro studies of muscle and metabolic disease in a variety of
experimental settings.EXPERIMENTAL PROCEDURES
Culture of Disassociated Blastomere Cells
Disassociated blastomere cells were grown in zESC medium composed of
70% LDF medium and 30% RTS34st-conditioned medium. LDF medium
contains 50% Leibowitz’s L-15 (Invitrogen), 35% DMEM (Invitrogen), and
15%Ham’s F-12 (Invitrogen), supplementedwith 0.18 g/l sodium bicarbonate,
15 mM HEPES (Invitrogen),1% L-Glutamine (Invitrogen), 10 mg/ml ciprofloxa-
cin (Sigma-Aldrich), 100 mg/ml piperacillin (Sigma-Aldrich), 10 mg/ml ampho-
tericin B (Sigma-Aldrich), 10 nM sodium selenite (Sigma-Aldrich), 1% N2
(Invitrogen), and 2% B27 (Invitrogen). RTS34st conditioned medium was
prepared by incubating fresh medium (Leibowitz’s L-15 plus 15% FBS) on a
confluent culture of RTS34st cells for 3 days.
High-Throughput Screen
Four 384-well plates were coated with 0.1% gelatin. Chemicals from the CHB
library (see Table S3) were diluted 150 times with zESC medium containing
1 ng/ml bFGF and were aliquoted 30 ml per well. Males and females of the
myf5-GFP;mylz2-mCherry transgenic line were set up overnight and kept
separated until morning when they were mixed for mating. Approximately
800 oblong-stage embryos were washed three times with E3 embryo water
and treated with pronase to remove chorions. Dechorionated embryos were
washed with E3 embryo water three times and collected into a 50 ml falcon
tube with 25 ml zESC medium containing 1 ng/ml bFGF. Embryos were disas-
sociated by shaking 20 times and were filtered through a 70 mm nylon mesh
filter. Resulting single cells were diluted to 60ml with zESCmedium containing
1 ng/ml bFGF and aliquoted 30 ml per well into the four 384-well plates with pre-
added chemicals. Cells were cultured in a 28C incubator without CO2. Cells
were imaged by a Celigo cytometer (Cyntellect). Images were analyzed by
the built-in software and confirmed by eye.
Satellite Cell Isolation and Culture
Satellite cell isolation was performed as previously described (Cerletti et al.,
2008; Sherwood et al., 2004). For in vitro expansion experiments, CD45-
Sca-1Mac-1CXCR4+b1-integrin+ cells were seeded on collagen/laminin-
coated plates in F10 (GIBCO) containing 20% horse serum (Atlanta Biologics),
1% penicillin-streptomycin (Invitrogen), and 1% glutamax (Invitrogen). Where
indicated, 5 ng/ml bFGF (Sigma) was added to the medium daily. 50 mM for-
skolin (Santa Cruz) or 0.1% DMSO was added to the wells 24 hr after plating,
and the medium was changed with fresh medium containing DMSO or forsko-
lin 48 hr after plating with treatment continued for 36 more hours, after which
the medium was changed for fresh medium without compound. Cells were
counted or used for transplant after 5 days in culture. For myogenic colony-
forming assays, cells were fixed and counted after 6 days in culture. For differ-
entiation, cells were cultured 5 days with or without compound, and on day 5,
equal numbers (8,000) of cells were replated in each well of a 96-well plate in
growthmedium. Mediumwas changed after 4 hr to DMEM (GIBCO) containing
2% horse serum (Atlanta Biologics), 1% penicillin-streptomycin (Invitrogen),
with or without 50 mM Forskolin or 0.1% DMSO. Cells were fixed after 60 or
72 hr in differentiation medium.
Tissue Injury and Mouse Satellite Cell Transplantation
25 ml (0.03 mg/ml) of Naja mossambica mossambica cardiotoxin (Sigma) was
injected in the tibialis anterior (TA) muscle of anesthetized mdx mice 1 day
before cell transplantation. The next day, 6,000 freshly isolated double-sorted
GFP+ satellite cells or the total number of cells expanded from 6,000 SMPs
after 5 days in culture were injected directly into these preinjured muscles in
20 ml PBS. For transplantation with equal numbers of cultured compound
treated cells, 200,000 forskolin or 200,000 DMSO-treated cells were injected.
The contralateral TA was injected with PBS only as a negative control. Trans-
planted muscles were harvested 3–4 weeks after transplant and analyzed by
cryosectioning and microscopy.
Culture and Differentiation of Human iPSCs
BJ-iPSCs (Maherali et al., 2008) were obtained from Chad Cowan (Harvard
Stem Cell Institute). 05400 and 00409 iPSCs lines were generated from
human adult skin fibroblasts by retroviral transduction of KLF4, SOX2,
OCT4, and c-MYC reprogramming factors as in Takahashi et al. (2007) and
Park et al. (2008). Pluripotency of these lines was assessed by colony
morphology; immunostaining for NANOG, OCT4, SSEA3-4, and Tra1-60;
gene expression of NANOG, OCT4, SOX2, REX1, TERT, and DNm3b; and
EB formation. Pluripotent iPSCs were maintained on matrigel-coated dishes
(BD) in mTeSR1 medium (STEMCELL Technologies). iPSCs were differenti-
ated to skeletal muscle by generating EBs in suspension culture for 7 days
and then transferred to matrigel-coated plates for an additional 29 days. Dur-
ing suspension culture, the cells received differentiation medium STEMDiff
Apel medium (STEMCELL technologies) supplemented with 10 ng/ml bFGF
(Invitrogen), 0.5 mM BIO (Santa Cruz Biotechnologies), and 20 mM forskolin
(Santa Cruz Biotechnologies). 2 to 3 days after plating EBs, the medium
was switched to DMEM supplemented with 2% horse serum for the remain-
ing differentiation.Transplantation of iPSC-Derived Muscle Progenitors
5- to 6-week-old NSG mice from Jackson Laboratories (stock #002378) were
preinjured by intramuscular injection of 0.03 mg/ml cardiotoxin 1 day prior to
cell transplantation. After 24 hr, myogenic progenitors (1 3 105 cells/ 25 ml
PBS) were injected into the left TAmuscle, whereas the right leg of eachmouse
received the same amount of PBS as a negative control. Onemonth later, mice
were sacrificed, andmuscles were harvested and frozen in iso-pentane cooled
in liquid nitrogen. Serial cryosections were fixed with 4% PFA and stained with
anti-d-Sarcoglycan (Leica), anti-Laminin (Abcam), anti-histone H2A (Santa
Cruz), and anti-Pax7 (R&D) antibodies. We observed no tumor formation in
mice followed for up to 45 days after transplant of iPSC-derivedmyogenic pro-
genitors; it will be important to perform longer-term follow up to fully exclude
tumorigenic potential in these cells.SUPPLEMENTAL INFORMATION
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